Current controversies in prenatal diagnosis 1: NIPT for chromosome abnormalities should be offered to women with low a priori risk.
In its successful annual cycle of controversies and debates, the International Society of Prenatal Diagnosis and Therapy once again addressed non-invasive prenatal testing (NIPT) by following up on the 2013 controversy, 'Should non-invasive DNA testing be the standard screening test for Down syndrome in all pregnant women'? with the proposition, 'NIPT for chromosomel abnormalities should be offered to women with low a priori risk'.
Department of Obstetrics and Fetal Medicine, Leiden University Medical Center, LUMC, Leiden, The Netherlands.
Jan M M
JM
Van Lith
Brigitte H W
BH
Faas
Diana W
DW
Bianchi
D025063:Chromosome Disorders / Q000097:blood / Q000175:diagnosis* / Q000209:etiology; D004314:Down Syndrome / Q000097:blood / Q000175:diagnosis; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000379:methods*; D012307:Risk Factors